These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Base excision repair proteins couple activation-induced cytidine deaminase and endonuclease G during replication stress-induced MLL destabilization. Gole B; Mian E; Rall M; Wiesmüller L Leukemia; 2018 Jan; 32(1):159-167. PubMed ID: 28626219 [TBL] [Abstract][Full Text] [Related]
43. New insights to the MLL recombinome of acute leukemias. Meyer C; Kowarz E; Hofmann J; Renneville A; Zuna J; Trka J; Ben Abdelali R; Macintyre E; De Braekeleer E; De Braekeleer M; Delabesse E; de Oliveira MP; Cavé H; Clappier E; van Dongen JJ; Balgobind BV; van den Heuvel-Eibrink MM; Beverloo HB; Panzer-Grümayer R; Teigler-Schlegel A; Harbott J; Kjeldsen E; Schnittger S; Koehl U; Gruhn B; Heidenreich O; Chan LC; Yip SF; Krzywinski M; Eckert C; Möricke A; Schrappe M; Alonso CN; Schäfer BW; Krauter J; Lee DA; Zur Stadt U; Te Kronnie G; Sutton R; Izraeli S; Trakhtenbrot L; Lo Nigro L; Tsaur G; Fechina L; Szczepanski T; Strehl S; Ilencikova D; Molkentin M; Burmeister T; Dingermann T; Klingebiel T; Marschalek R Leukemia; 2009 Aug; 23(8):1490-9. PubMed ID: 19262598 [TBL] [Abstract][Full Text] [Related]
44. Dietary flavonoids induce MLL translocations in primary human CD34+ cells. Barjesteh van Waalwijk van Doorn-Khosrovani S; Janssen J; Maas LM; Godschalk RW; Nijhuis JG; van Schooten FJ Carcinogenesis; 2007 Aug; 28(8):1703-9. PubMed ID: 17468513 [TBL] [Abstract][Full Text] [Related]
45. Model for MLL translocations in therapy-related leukemia involving topoisomerase IIβ-mediated DNA strand breaks and gene proximity. Cowell IG; Sondka Z; Smith K; Lee KC; Manville CM; Sidorczuk-Lesthuruge M; Rance HA; Padget K; Jackson GH; Adachi N; Austin CA Proc Natl Acad Sci U S A; 2012 Jun; 109(23):8989-94. PubMed ID: 22615413 [TBL] [Abstract][Full Text] [Related]
46. Polymorphisms in the MLL breakpoint cluster region (BCR). Echlin-Bell DR; Smith LL; Li L; Strissel PL; Strick R; Gupta V; Banerjee J; Larson R; Relling MV; Raimondi SC; Hayashi Y; Taki T; Zeleznik-Le N; Rowley JD Hum Genet; 2003 Jul; 113(1):80-91. PubMed ID: 12665971 [TBL] [Abstract][Full Text] [Related]
47. DNA fragility at the Cowell IG; Austin CA Open Biol; 2023 Jan; 13(1):220232. PubMed ID: 36629017 [TBL] [Abstract][Full Text] [Related]
48. PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease. Li Z; Chen P; Su R; Hu C; Li Y; Elkahloun AG; Zuo Z; Gurbuxani S; Arnovitz S; Weng H; Wang Y; Li S; Huang H; Neilly MB; Wang GG; Jiang X; Liu PP; Jin J; Chen J Cancer Res; 2016 Feb; 76(3):619-29. PubMed ID: 26747896 [TBL] [Abstract][Full Text] [Related]
49. Characterization and mechanisms of chromosomal alterations induced by benzene in mice and humans. Eastmond DA; Schuler M; Frantz C; Chen H; Parks R; Wang L; Hasegawa L Res Rep Health Eff Inst; 2001 Jun; (103):1-68; discussion 69-80. PubMed ID: 11504146 [TBL] [Abstract][Full Text] [Related]
50. Leukemia cells impair normal hematopoiesis and induce functionally loss of hematopoietic stem cells through immune cells and inflammation. Cui P; Zhang Y; Cui M; Li Z; Ma G; Wang R; Wang N; Huang S; Gao J Leuk Res; 2018 Feb; 65():49-54. PubMed ID: 29306107 [TBL] [Abstract][Full Text] [Related]
52. Ataxia telangiectasia mutated-dependent regulation of topoisomerase II alpha expression and sensitivity to topoisomerase II inhibitor. Tamaichi H; Sato M; Porter AC; Shimizu T; Mizutani S; Takagi M Cancer Sci; 2013 Feb; 104(2):178-84. PubMed ID: 23163762 [TBL] [Abstract][Full Text] [Related]
53. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia. Super HG; Strissel PL; Sobulo OM; Burian D; Reshmi SC; Roe B; Zeleznik-Le NJ; Diaz MO; Rowley JD Genes Chromosomes Cancer; 1997 Oct; 20(2):185-95. PubMed ID: 9331569 [TBL] [Abstract][Full Text] [Related]
54. DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis. Strissel PL; Strick R; Tomek RJ; Roe BA; Rowley JD; Zeleznik-Le NJ Hum Mol Genet; 2000 Jul; 9(11):1671-9. PubMed ID: 10861294 [TBL] [Abstract][Full Text] [Related]
56. Leukemias related to treatment with DNA topoisomerase II inhibitors. Felix CA Med Pediatr Oncol; 2001 May; 36(5):525-35. PubMed ID: 11340607 [TBL] [Abstract][Full Text] [Related]
57. Nucleotide-resolution mapping of topoisomerase-mediated and apoptotic DNA strand scissions at or near an MLL translocation hotspot. Mirault ME; Boucher P; Tremblay A Am J Hum Genet; 2006 Nov; 79(5):779-91. PubMed ID: 17033956 [TBL] [Abstract][Full Text] [Related]
58. Use of Genome Engineering to Create Patient Specific MLL Translocations in Primary Human Hematopoietic Stem and Progenitor Cells. Breese EH; Buechele C; Dawson C; Cleary ML; Porteus MH PLoS One; 2015; 10(9):e0136644. PubMed ID: 26351841 [TBL] [Abstract][Full Text] [Related]
59. A novel chromosomal inversion at 11q23 in infant acute myeloid leukemia fuses MLL to CALM, a gene that encodes a clathrin assembly protein. Wechsler DS; Engstrom LD; Alexander BM; Motto DG; Roulston D Genes Chromosomes Cancer; 2003 Jan; 36(1):26-36. PubMed ID: 12461747 [TBL] [Abstract][Full Text] [Related]
60. Stress hematopoiesis reveals abnormal control of self-renewal, lineage bias, and myeloid differentiation in Mll partial tandem duplication (Mll-PTD) hematopoietic stem/progenitor cells. Zhang Y; Yan X; Sashida G; Zhao X; Rao Y; Goyama S; Whitman SP; Zorko N; Bernot K; Conway RM; Witte D; Wang QF; Tenen DG; Xiao Z; Marcucci G; Mulloy JC; Grimes HL; Caligiuri MA; Huang G Blood; 2012 Aug; 120(5):1118-29. PubMed ID: 22740449 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]